Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

523
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
523
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

798
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
798
Long-term Depression01:05

Long-term Depression

33.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.3K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

40.3K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.3K
Depressants01:28

Depressants

450
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
450
Cognitive Dissonance01:38

Cognitive Dissonance

37.5K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
37.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postoperative Transthoracic Echocardiography Following Penetrating Cardiac Injury: Moving From Routine Use to a Risk-Stratified Approach.

The American surgeon·2026
Same author

Artificial intelligence-enabled plaque characterization from coronary computed tomography establishes basis of angina in women with nonobstructive atherosclerosis.

Communications medicine·2026
Same author

Association between eating disorders and functional gastrointestinal disorders: a systematic review.

Frontiers in psychology·2026
Same author

American Association for the Surgery of Trauma/American College of Surgeons-Committee on Trauma Clinical Consensus Statement on the management of patients with rib fractures.

The journal of trauma and acute care surgery·2026
Same author

High scan-rescan repeatability of AI-enabled coronary plaque quantification from coronary CT angiography.

European radiology·2026
Same author

Surgical Intervention for Morel-Lavallee Injury: Early, Late or Never?

Journal of the American College of Surgeons·2026

Related Experiment Video

Updated: Feb 5, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.5K

Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder.

Roger S McIntyre1, Yena Lee, Nicole E Carmona

  • 1From the Mood Disorders Psychopharmacology Unit, University Health Network, Canada; Institute of Medical Science (Drs. McIntyre and Rosenblat, Ms. Lee, and Mr. Pan), Department of Psychiatry (Drs. McIntyre, Rosenblat, and Mansur), and Department of Pharmacology (Dr. McIntyre), University of Toronto; Paik Institute for Clinical Research, Inje University (Republic of Korea) (Dr. J Lee); Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine (Republic of Korea) (Dr. J-G Lee); Department of Psychiatry, College of Medicine, Imam University (Saudi Arabia) (Dr. Alageel).

Harvard Review of Psychiatry
|September 7, 2018
PubMed
Summary

Cognitive dysfunction is a core symptom of major depressive disorder (MDD) impacting patient outcomes. Emerging treatments are being investigated to address this critical aspect of MDD.

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.4K

Related Experiment Videos

Last Updated: Feb 5, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.5K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.4K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • Cognitive dysfunction is a central feature of major depressive disorder (MDD), not a secondary symptom.
  • It significantly impacts patient-reported outcomes and is inadequately addressed by current MDD treatments.
  • Neural substrates of cognitive function in MDD are distinct yet overlapping with emotion processing areas.

Purpose of the Study:

  • To characterize cognitive dysfunction in major depressive disorder (MDD).
  • To evaluate current and emerging treatment approaches for cognitive dysfunction in MDD patients.

Main Methods:

  • Review of existing literature on cognitive dysfunction in MDD.
  • Analysis of factors influencing cognitive dysfunction, including clinical features and comorbidities.
  • Examination of available screening and measurement tools.
  • Evaluation of pharmacological and non-pharmacological treatment strategies.

Main Results:

  • Cognitive dysfunction in MDD is a core domain with significant impact on patient outcomes.
  • Modifiable factors like clinical features, comorbidities, and iatrogenic effects influence cognitive dysfunction.
  • While some antidepressants show procognitive effects, rigorous evaluation is often lacking.
  • Various promising treatment avenues, including pharmacological and psychosocial interventions, are under investigation.

Conclusions:

  • Cognitive dysfunction is a critical, under-treated domain in major depressive disorder (MDD).
  • Effective screening and measurement tools are available.
  • Further research and rigorous evaluation of novel therapeutic strategies are essential to improve patient outcomes in MDD.